Published October 9, 2018 | Version v1
Project deliverable Open

D9.5 Report on implementation of ELSI and policy consideration for controlled access data

Description

The EXCELERATE WP9 focuses on the human data use case. It provides technical extension to the permanent archive for all types of controlled access data, the European Genome-phenome Archive (EGA), that will support genomic information deposition, data
management and sharing within local jurisdiction.
This report focuses on describing the improvement on the EGA processes that support the use of controlled data access protocol and compliance to the ELIXIR ELSI Policy and the European General Data Protection Regulation (GDPR). It also provides terminology
translation between EXCELERATE WP9 technical reports, the ELSI terminology and the GDPR.
Currently the EGA service is provided by two European organisations based on a bilateral agreement. The technical solutions delivered during the EXCELERATE WP9 will require a legal framework to enable federated EGA services.

Files

D9.5 Final.pdf

Files (522.7 kB)

Name Size Download all
md5:12f7ca9cc6624fa89dc097e78f50a706
522.7 kB Preview Download

Additional details

Funding

ELIXIR-EXCELERATE – ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences. 676559
European Commission